Literature DB >> 21422306

Carhart notch 2-kHz bone conduction threshold dip: a nondefinitive predictor of stapes fixation in conductive hearing loss with normal tympanic membrane.

Akinori Kashio1, Ken Ito, Akinobu Kakigi, Shotaro Karino, Shin-Ichi Iwasaki, Takashi Sakamoto, Takuya Yasui, Mitsuya Suzuki, Tatsuya Yamasoba.   

Abstract

OBJECTIVE: To evaluate the significance of the Carhart notch (a 2-kHz bone conduction threshold dip [2KBD]) in the diagnosis of stapes fixation by comparing its incidence among ears with various ossicular chain abnormalities.
DESIGN: Retrospective study.
SETTING: University hospital. PATIENTS: A total of 153 ears among 127 consecutive patients with a congenital ossicular anomaly or otosclerosis. MAIN OUTCOME MEASURES: The 2KBD depth was defined as the threshold at 2 kHz minus the mean of thresholds at 1 and 4 kHz. The presence of 2KBD (depth, ≥10 dB), 2KBD depth, relationship between 2KBD depth and air-bone gap, and 2-kHz bone conduction recovery after operation were evaluated in a stapes fixation group (which included cases of otosclerosis and congenital stapes fixation), an incudostapedial joint detachment group, and a malleus or incus fixation group.
RESULTS: A 2KBD was present in 32 of 102 stapes fixation ears (31.4%), 5 of 19 incudostapedial joint detachment ears (26.3%), and 6 of 20 malleus or incus fixation ears (30.0%) (12 ears had other diagnoses). The mean (SD) 2KBD depths were 17.3 (5.2) dB in the stapes fixation group, 18.5 (2.2) dB in the incudostapedial joint detachment group, and 16.3 (2.1) dB in the malleus or incus fixation group. No statistically significant differences were noted among these 3 groups. No correlation was noted between 2KBD depth and air-bone gap extent. Recovery of 2-kHz bone conduction threshold in the stapes fixation group was less than that in the other 2 groups.
CONCLUSION: Incidence of 2KBD was similar among the stapes fixation, incudostapedial joint detachment, and malleus or incus fixation groups, implying that 2KBD is not a useful predictor of stapes fixation.

Entities:  

Mesh:

Year:  2011        PMID: 21422306     DOI: 10.1001/archoto.2011.14

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  8 in total

1.  Bone conduction hearing in congenital aural atresia.

Authors:  Lichun Zhang; Na Gao; Yanbo Yin; Lin Yang; Youzhou Xie; Ying Chen; Peidong Dai; Tianyu Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-24       Impact factor: 2.503

2.  Role of HRCT Temporal Bone in Predicting Surgical Difficulties Encountered in Fenestral Otosclerosis Surgery.

Authors:  Sandeep Govindan Prasad; Suma Radhakrishnan; E Devarajan; Rinu Susan Thomas; Lin Varghese
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-02-06

3.  Long-term hearing results of stapedotomy: analysis of factors affecting outcome.

Authors:  Ingeborg Dhooge; Stéphanie Desmedt; Thomas Maly; David Loose; Helen Van Hoecke
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-02-16       Impact factor: 2.503

Review 4.  Mass and Stiffness Impact on the Middle Ear and the Cochlear Partition.

Authors:  Jinsook Kim; Miseung Koo
Journal:  J Audiol Otol       Date:  2015-04-17

5.  Does bilateral otosclerosis make pre-operative bone conduction more inaccurate?

Authors:  Fiona McClenaghan; Jeremy Lavy
Journal:  J Otol       Date:  2020-07-20

6.  Right Incus Osteoma in a Child: A Differential Diagnosis of Middle Ear Malformations.

Authors:  Charlotte Benoit; Emilien Chebib; Ophélie Bloy; Monique Elmaleh; Guillaume Morcrette; Thierry Van Den Abbeele
Journal:  J Int Adv Otol       Date:  2021-11       Impact factor: 1.017

7.  A Case of Isolated Congenital Stapedial Suprastructure Fixation.

Authors:  Jeon Mi Lee; Hyun Jin Lee; Sung Huhn Kim
Journal:  Case Rep Otolaryngol       Date:  2022-03-19

8.  Pedigree Analysis and Audiological Investigations of Otosclerosis: An Extended Family Based Study.

Authors:  Santhanam Rekha; Ravi Ramalingam; Madasamy Parani
Journal:  J Audiol Otol       Date:  2018-06-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.